Simplify Medical makes the Simplify® cervical artificial disc, an MRI-friendly PEEK-on-ceramic device designed to minimize post-operative CT scans and reduce patient exposure to ionizing radiation. The Simplify Disc features no metal articulating components for low wear, low-height implant options, and a straightforward three-step implantation; it is considered MRI-conditional. The device has received the CE Mark and is commercially available in select European markets, with early clinical data showing substantial pain and functional improvement. The company is using Series B funding to complete two ongoing U.S. pivotal trials — one-level and two-level cervical implantation studies — and to support commercialization outside the U.S. Simplify Medical completed an oversubscribed second tranche of its Series B, bringing the round to $44.25 million. The company is based in Sunnyvale, California. Simplify Medical develops the Simplify® cervical artificial disc using MRI-friendly materials intended to avoid metal artifact and reduce the need for CT and ionizing radiation. The device is designed to avoid metal wear and offers a low-profile implant to expand patient eligibility. The Simplify Disc has received the CE Mark and has been used to treat more than 700 patients outside the U.S. over the last three years, with early clinical data showing substantial improvements in pain scores and function. Simplify Medical is conducting two U.S. pivotal trials: a prospective two-level trial of up to 200 patients at up to 15 centers comparing two-level implantation with two-level fusion, and a one-level trial using a historical nonconcurrent control group. The company will use new funding to complete these ongoing pivotal trials as part of its pathway toward availability for U.S. patients. Simplify Medical is located in Sunnyvale, California.

Total raised

$44M

Funding rounds

2

Latest round

Series B

Latest activity

Feb 2018